UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lithology and reservoir properties of the Delaware Mountain Group of the Delaware Basin and implications for saltwater disposal and induced seismicity

Journal of sedimentary research, 2021-11, Vol.91 (11), p.1113-1132

2021

Volltextzugriff (PDF)

LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10 (Issue 1), p.1015-1026

2015

Volltextzugriff (PDF)

The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD

International journal of chronic obstructive pulmonary disease, 2017-01, Vol.12, p.1325-1337

2017

Volltextzugriff (PDF)

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study

International journal of chronic obstructive pulmonary disease, 2017-01, Vol.12, p.339-349

2017

Volltextzugriff (PDF)

Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma

Annals of allergy, asthma, & immunology, 2005-04, Vol.94 (4), p.465-472

2005

Volltextzugriff (PDF)

Ciclesonide, a Novel Inhaled Steroid, Does Not Affect Hypothalamic-Pituitary-Adrenal Axis Function in Patients With Moderate-to-Severe Persistent Asthma

Chest, 2005-09, Vol.128 (3), p.1104-1114

2005

Volltextzugriff (PDF)

Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum]

International journal of chronic obstructive pulmonary disease, 2017-01, Vol.12, p.231-232

2017

Volltextzugriff (PDF)

Early Clinically Important Improvement (ECII) and Exacerbation Outcomes in COPD Patients

International journal of chronic obstructive pulmonary disease, 2020-01, Vol.15, p.1831-1838

2020

Volltextzugriff (PDF)

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study

International journal of chronic obstructive pulmonary disease, 2018-01, Vol.13, p.1125-1134

2018

Volltextzugriff (PDF)

Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study

International journal of chronic obstructive pulmonary disease, 2016-01, Vol.11 (1), p.2543-2551

2016

Volltextzugriff (PDF)

Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study [Corrigendum]

International journal of chronic obstructive pulmonary disease, 2014-01, Vol.9 (default), p.85-85

2014

Volltextzugriff (PDF)

Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis

International journal of chronic obstructive pulmonary disease, 2016-01, Vol.11, p.3189-3197

2016

Volltextzugriff (PDF)

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD [Corrigendum]

International journal of chronic obstructive pulmonary disease, 2014-01, Vol.9 (default), p.287-287

2014

Volltextzugriff (PDF)

Development of autonomous mobile robot with manipulator for manufacturing environment

International journal of advanced manufacturing technology, 2008-08, Vol.38 (5-6), p.536-542

2008

Volltextzugriff (PDF)

Room-temperature hydrogen sensor based on palladium nanowires

IEEE sensors journal, 2005-10, Vol.5 (5), p.792-797

2005

Volltextzugriff (PDF)

Giant vestibular schwannomas: focusing on the differences between the solid and the cystic variants

British journal of neurosurgery, 2008-08, Vol.22 (4), p.550-556

2008

Volltextzugriff (PDF)

Politics of rural health in India

Indian journal of public health, 2005-07, Vol.49 (3), p.113

Banerji, D

2005

Volltextzugriff (PDF)

P252 Once-daily NVA237 improves symptoms, and reduces COPD exacerbations and associated hospitalisations: the GLOW1 trial

Thorax, 2011-12, Vol.66 (Suppl 4), p.A170-A170

2011

Volltextzugriff (PDF)

P253 NVA237 once daily offers rapid and clinically meaningful bronchodilation in COPD patients that is maintained for 24 h: the GLOW1 trial

Thorax, 2011-12, Vol.66 (Suppl 4), p.A170-A170

2011

Volltextzugriff (PDF)

Protective efficacy of a monovalent oral type 1 poliovirus vaccine

The Lancet (British edition), 2007-07, Vol.370 (9582), p.129-129

2007

Volltextzugriff (PDF)

Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study

The European respiratory journal, 2014-06, Vol.43 (6), p.1599-1609

2014

Volltextzugriff (PDF)

Intracranial aneurysms in patients 18 years of age or under, are they different from aneurysms in adult population?

Acta neurochirurgica, 2005-05, Vol.147 (5), p.469-476

2005

Volltextzugriff (PDF)

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD

International journal of chronic obstructive pulmonary disease, 2012-01, Vol.7 (default), p.729-741

2012

Volltextzugriff (PDF)

Evidence-based National Vaccine Policy

Indian journal of medical research (New Delhi, India : 1994), 2010-05, Vol.131, p.617

2010

Volltextzugriff (PDF)

D36 COPD: LABA, LAMA, ICS, AND COMBINATIONS: Indacaterol/glycopyrrolate Improves Dyspnea In Us Patients With Moderate-To-Severe COPD: A Subgroup Analysis Of The Pooled Flight1 And Flight2 Studies

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

1 – 25 von 1.267

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(996)
Mit Volltextzugriff
(1.015)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Lithology and reservoir properties of the Delaware Mountain Group of the Delaware Basin and implications for saltwater disposal and induced seismicity

LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD

The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study

Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma

Ciclesonide, a Novel Inhaled Steroid, Does Not Affect Hypothalamic-Pituitary-Adrenal Axis Function in Patients With Moderate-to-Severe Persistent Asthma

Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum]

Early Clinically Important Improvement (ECII) and Exacerbation Outcomes in COPD Patients

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study

Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study

Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study [Corrigendum]

Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD [Corrigendum]

Development of autonomous mobile robot with manipulator for manufacturing environment

Room-temperature hydrogen sensor based on palladium nanowires

Giant vestibular schwannomas: focusing on the differences between the solid and the cystic variants

Politics of rural health in India

P252 Once-daily NVA237 improves symptoms, and reduces COPD exacerbations and associated hospitalisations: the GLOW1 trial

P253 NVA237 once daily offers rapid and clinically meaningful bronchodilation in COPD patients that is maintained for 24 h: the GLOW1 trial

Protective efficacy of a monovalent oral type 1 poliovirus vaccine

Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study

Intracranial aneurysms in patients 18 years of age or under, are they different from aneurysms in adult population?

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD

Evidence-based National Vaccine Policy

D36 COPD: LABA, LAMA, ICS, AND COMBINATIONS: Indacaterol/glycopyrrolate Improves Dyspnea In Us Patients With Moderate-To-Severe COPD: A Subgroup Analysis Of The Pooled Flight1 And Flight2 Studies

Suchergebnisse filtern